Some of these kinases have been implicated in cancer, such as mutant forms of the receptor tyrosine kinases FLT3 and DDR2, which have been identified in acute myeloid leukemia and lung cancer, respectively 19, 20. This evidence concerns the gene DDR2 and cancer.